Dr Mark Graham PhD, is an experienced Pharmaceutical Toxicologist (28 years) offering Drug Safety Assessment consultancy services to Pharmaceutical, Biotechnology and other Life Science Companies.  Mark spent 19 years with AstraZeneca where he had several senior scientific roles in Global Safety Assessment.  In addition to a career in Pharmaceutical R&D, Mark maintained activity in research via collaborations with several UK Universities involving the supervision of PhD students resulting in many peer-reviewed publications.  Mark is a Fellow of the British Toxicology Society and a past Member of the Committee On Toxicity (COT) which provides expert advice on chemical toxicity to the UK Government.  Mark is also a member of the editorial board of the journal Xenobiotica.

In addition to working as a preclinical safety consultant to the Pharma and Biotech industry, Mark has also founded a virtual Biotech company focused on creating novel immuno-oncology agents to treat cancer and has developed his own client base.